Increasing HIV testing and access to PrEP and PEP
Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention
['FUNDING_R01'] · COLUMBIA UNIV NEW YORK MORNINGSIDE · NIH-11397494
This project offers tools and community support to help people at higher risk get tested for HIV more often and start prevention medicines like PrEP or PEP.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIV NEW YORK MORNINGSIDE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11397494 on ClinicalTrials.gov |
What this research studies
You would be offered easier ways to test for HIV (including self-testing), online self-assessments, and help connecting to local prevention services through community organizations. The program mixes proven approaches with new tools and delivers them across community sites in New York City using different intervention combinations. The goal is to make testing every 3–6 months simpler and speed up access to PrEP or PEP when needed. If you are in a higher-risk group, these services are meant to help you stay on top of testing and prevention.
Who could benefit from this research
Good fit: People in New York City who are at higher risk for HIV—such as men who have sex with men, transgender people, those with recent STI diagnoses, or anyone with inconsistent testing—are the primary candidates.
Not a fit: People not at risk for HIV or those already in stable HIV care with regular testing are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: If successful, this could make it easier for people at risk to get regular HIV tests and start PrEP/PEP sooner, reducing new infections.
How similar studies have performed: Navigation to PrEP and community testing programs have shown benefit before, but combining self-testing, self-care tools, and multilevel community delivery in this way is relatively new.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIV NEW YORK MORNINGSIDE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FRYE, VICTORIA — COLUMBIA UNIV NEW YORK MORNINGSIDE
- Study coordinator: FRYE, VICTORIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus